GLUE 241220 22.50P (GLUE241220P22500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

GLUE241220P22500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 25 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Monte Rosa Therapeutics to Participate in the Piper Sandler Healthcare Conference
GlobeNewswire16minutes ago
Wall Street Analysts Think Monte Rosa Therapeutics (GLUE) Could Surge 100.47%: Read This Before Placing a Bet
Zacks Nov 15 09:15 ET
Owning 47% Shares,institutional Owners Seem Interested in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE),
Yahoo FinanceNov 11 07:45 ET
J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $15
Moomoo NewsNov 8 22:31 ET · Ratings
Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $14
Moomoo NewsNov 8 05:31 ET · Ratings
Express News | Monte Rosa Therapeutics Inc : JP Morgan Raises Target Price to $15 From $7
ReutersNov 8 00:27 ET

Comments

MrSuperStonk

Nov 7 12:38

$Monte Rosa Therapeutics (GLUE.US)$ thats pretty good revenue. But dont buy here. wait for it to calm down.

Jaguar8

Oct 30 16:39

NEWS

$Monte Rosa Therapeutics (GLUE.US)$
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.

Jaguar8

Oct 30 15:39

NEWS

$Monte Rosa Therapeutics (GLUE.US)$
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.

Rivera

Oct 29 11:03

To 20 soon

$Monte Rosa Therapeutics (GLUE.US)$

Jaguar8

Oct 28 22:28

Watch on this. It ran today but this is a huge news- partnership with Novartis. Trade the chart

$Monte Rosa Therapeutics (GLUE.US)$